Nausea Relief Chews Market

Nausea Relief Chews Market Analysis by Gastroesophageal Reflux Disease, Motion Sickness, and Sea Sickness from 2023 to 2033

Analysis of Nausea Relief Chews Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Nausea Relief Chews Market Outlook (2023 to 2033)

Newly-released nausea relief chews market analysis report by Fact.MR reveals that global sales of the nausea relief chews market in 2022 were held at US$ 334 million. With 7.2% projected growth from 2023 to 2033, the market is expected to reach a valuation of US$ 712.9 million by the end of the forecast period.

Nausea relief chews based on gastroesophageal reflux disease is expected to be the highest revenue-generating category, projected to grow at a CAGR of over 7% from 2023 to 2033.

Attributes Details

Global Nausea Relief Chews Market Size (2022)

US$ 334 million

Global Nausea Relief Chews Market Size (2033)

US$ 712.9 million

Global Nausea Relief Chews Market CAGR (2023 to 2033)

7.2%

U.S. Nausea Relief Chews Market CAGR (2023 to 2033)

7%

Key Companies Covered

  • Prestige Consumer Healthcare Inc.
  • Megafood
  • Webber Naturals
  • Merck
  • Sanofi
  • Nauzene
  • Pepto Bismol
  • Ginger People
  • Emetrol Chewables
  • Cipla

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Revenue of Nausea Relief Chews Market from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033

As per the research of the nausea relief chews market by Fact.MR - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around 5.6% CAGR. With an absolute dollar opportunity of US$ 356.1 million, the market is projected to reach a valuation of US$ 712.9 million by 2033.

What Key Drivers are Influencing the Market Expansion?

Nausea relief chews are a type of over-the-counter medication used to provide relief from nausea and vomiting. These chews are typically formulated with natural ingredients such as ginger, peppermint, or chamomile, which have been traditionally used to alleviate gastrointestinal discomfort. Nausea relief chews are available in different flavors and are designed to be chewed and swallowed like candy.

  • In 2020, the global nausea relief products market was valued at over US$ 2.5 billion and it is expected to grow at a CAGR of 5.6% during the forecast period. Nausea and vomiting are common symptoms associated with various medical conditions such as pregnancy, motion sickness, chemotherapy, and post-operative recovery. With an increasing prevalence of these conditions, the demand for nausea relief chews is expected to rise in the upcoming years.

According to the International Agency for Research on Cancer (IARC), in 2018, about 18.1 million new cancer cases were diagnosed worldwide which increased to the next year was about 18.6 million new cancer cases. The most commonly diagnosed types of cancer worldwide are lung cancer, breast cancer, and colorectal cancer.

  • In 2018, lung cancer accounted for 11.6% of all new cancer cases, followed by breast cancer with 11.6% and colorectal cancer with 10.2%. Nausea relief chews can provide several benefits for cancer patients who experience nausea and vomiting due to chemotherapy or radiation therapy. These chews are designed to deliver fast-acting relief for nausea, with a convenient and easy-to-use form. Thus, nausea relief chews witness an increase in sales due to the growing prevalence of cancer during the forecast period.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Region-Wise Analysis :

Which Region is projected to offer Significant Growth in the Market?

North America is a prominent shareholder in the market with a market size of US$ 93.5 million. It is projected that the region will have a market worth US$ 199.6 million by 2033.

In 2021, over 2.3 million new cancer cases were diagnosed and 30 thousand cases of lung and bronchus cancer were diagnosed in Canada. Besides, over 21 thousand deaths were caused due to lung cancer in 2020. Due to the rise in cancer cases, chemotherapy is a widely used treatment for various types of cancer which is also accompanied by side effects of nausea and vomiting. Nausea relief chews are formulated to deliver fast-acting relief for nausea and vomiting which is expected to influence the market growth in the forthcoming years.

Country-Wise Analysis :

United States Nausea Relief Chews Market Analysis :

The market in the United States is expected to grow to be worth US$ 172.1 million by 2033, with an absolute dollar growth of US$ 84.2 million from 2023 to 2033. The market in the country has grown at a CAGR of 5.3% from 2018 to 2022 and is expected to grow at a CAGR of 7% from 2023 to 2033.

In 2019, according to the American Cancer Society, an estimated 1.76 million new cancer cases were diagnosed in the United States. Breast cancer and lung cancer were the leading causes of death. Over 271 thousand cases diagnosed with breast cancer and about 228 thousand cases diagnosed with lung cancer.

Due to increase in the incidences of cancer, chemotherapy is used as a standard treatment for the all types of cancer which causes side-effects including nausea and vomiting. Nausea relief chews made from natural and herbal products used for the relieving of nausea and vomiting is expected to influence the market growth in the future.

Germany Nausea Relief Chews Market Analysis :

The market in Germany is expected to grow to be worth US$ 26.2 million by 2033, with an absolute dollar growth of US$ 11.9 million. The market in the country has grown at a CAGR of 4.5% from 2018 to 2022 and is expected to grow at a CAGR of 6.2% from 2023 to 2033.

According to the German Pancreatic Cancer Foundation, in 2020, the incidence of acute pancreatitis in the country had a population coverage of around 80 -100 cases per 100,000 people. The incidence of chronic pancreatitis is lower, estimated to be around 5-10 cases per 100,000 people per year. Nausea relief chews may be used as a part of the treatment for nausea and vomiting associated with pancreatitis, especially in cases of acute pancreatitis. The growing need for nausea chews for the treatment of nausea and vomiting is expected to influence the market growth in the upcoming years.

China Nausea Relief Chews Market Analysis :

In China, the market is expected to grow to be worth US$ 89 million with an absolute dollar growth of US$ 41.9 million. The market in China has grown at a CAGR of 5% from 2018 to 2022 and is expected to grow at a CAGR of 6.6% from 2023 to 2033.

In 2020, the market in China was valued at about US$ 50 million. The market is expected to grow at a CAGR of 10.4% during the forecast period, reaching a value of around US$ 1.2 billion by 2028. The demand for antiemetic drugs in China is likely to continue growing in the coming years due to the increasing prevalence of chronic diseases and a growing awareness of the use of antiemetic drugs. This is expected to influence the market growth in the forthcoming years.

India Nausea Relief Chews Market Analysis :

The market is expected to grow to be worth US$ 72.7 million by 2033, with an absolute dollar growth of US$ 30.9 million. The market in India has grown at a CAGR of 4.1% from 2018 to 2022 and is expected to grow at a CAGR of 5.7% from 2023 to 2033.

According to a study published in the Indian Journal of Gastroenterology, in 2018, the prevalence of irritable bowel syndrome (IBS) in India is estimated to be around 5-12%. This means that around 64 to 153 million people in India may be suffering from IBS. Nausea Relief Chews are generally over-the-counter medications which can help to alleviate nausea and vomiting. This contains ginger or peppermint that has shown anti-inflammatory and anti-nausea properties.

United Kingdom Nausea Relief Chews Market Analysis :

In United Kingdom, the market is expected to grow to be worth US$ 44.5 million with an absolute dollar growth of US$ 18.1 million. The market in Japan has grown at a CAGR of 3.5% from 2018 to 2022 and is expected to grow at a CAGR of 5.4% from 2023 to 2033.

In 2020, there were around 9 million people in the United Kingdom who experienced migraines while the prevalence rate of migraines in the UK was around 14% of the total population. Nausea relief chews are commonly used to help alleviate nausea that may be associated with migraines. The growing incidences of migraines will thus drive the market growth in the forthcoming years.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-Wise Insights

Which Indication of Nausea Relief Chews is projected to Witness Significant Growth?

The market through gastroesophageal reflux disease indication is projected to witness significant growth with a CAGR of 5.4% from 2018 to 2022. The market is expected to grow at a CAGR of 7% from 2023 to 2033.

Gastroesophageal Reflux Disease (GERD) is a chronic condition where stomach acid flows back into the oesophagus, causing irritation and inflammation. Symptoms may include heartburn, regurgitation, difficulty swallowing, and nausea. Nausea relief chews may help alleviate nausea associated with GERD. The convenience of these chews makes them a common choice for people, who prefer natural remedies and easy-to-use medication.

Through which Distribution Channel is the Market Projected to Witness Significant Growth?

The market is expected to witness growth through online sales at a CAGR of 5.2% from 2018 to 2022. The market is further expected to grow at a CAGR of 6.6% from 2023 to 2033.

Nausea relief chews includes various brands and products that are available over-the-counter (OTC) in pharmacies, drug stores, supermarkets, and online retailers. The growth of online sales may be driven by factors such as convenience, accessibility, and the ability to easily compare prices and products.

Competitive Analysis :

Key players in the market are Prestige Consumer Healthcare Inc., Megafood, Webber Naturals, Merck, Sanofi, Nauzene, Pepto Bismol, Ginger People, Emetrol Chewables and Cipla.

A few of the recent developments in the market are :

  • In August 2021, Pfizer Consumer Healthcare announced the launch of its new product, Pepto Bismol Nausea Relief Chewables, which are designed to provide fast and effective relief from nausea, heartburn, and indigestion. The product is formulated with a combination of bismuth subsalicylate and ginger, which are known to have anti-nausea and anti-inflammatory properties.
  • In January 2021, Pink Stork announced the launch of its new product, Morning Sickness Relief Chews which are designed specifically for pregnant women. The product is formulated with a combination of ginger and vitamin B6, and is intended to provide fast and effective relief from nausea and vomiting during pregnancy.

Segmentation of the Nausea Relief Chews Market :

  • By Indication :

    • Gastroesophageal Reflux Disease
    • Motion Sickness and Seasickness
  • By Distribution Channel :

    • Online Sales
    • Supermarkets/Hypermarkets
    • Hospital Pharmacies
  • By Region :

    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa

- FAQs -

What value is the market estimated to reach in 2023?

The global market size is estimated to be valued at US$ 356.8 million in 2023.

What was the global market size for 2022?

The market was reported at US$ 334 million in 2022.

What valuation is the market estimated to reach by 2033?

The market is expected to reach a valuation of US$ 712.9 million by 2033.

What value CAGR did the market exhibit over the last 4 years?

The market registered a CAGR of 5.6% over the last 4 years.

What is the projected CAGR for the market from 2023 to 2033?

The market is projected to witness a CAGR of 7.2% from 2023 to 2033.

Which indication of nausea relief chews leads to significant sales?

Gastroesophageal Reflux Disease is the top indication of nausea relief chews which is projected to witness significant demand with a projected CAGR of 7% from 2023 to 2033.

What is the expected market size in the United States by 2033?

The market in the United States is projected to witness a market size of US$ 172.1 million and is expected to grow at a 7% CAGR from 2023 to 2033.

Which are the key companies offering Nausea Relief Chews?

Key players in the market are Prestige Consumer Healthcare Inc., Megafood, Webber Naturals, Merck, Sanofi, Nauzene, Pepto Bismol, Ginger People, Emetrol Chewables and Cipla.

- Also of Interest -

OTC Cough, Cold and Allergy Medicine Market

OTC Cough, Cold and Allergy Medicine Market Forecast by Drug Type (Antihistamine, Expectorants, Bronchodilators, and Antibiotics), by OTC Channel (Pharmacies, Drug Store, Modern Trade Online Sales), by Dosage (Capsules, Liquid, Lozenges), by Application, and by Region - 2022 to 2032

OTC Pediatric Healthcare Market

OTC Pediatric Healthcare Market Analysis by Gastrointestinal, Dermatology, ENT, and Nutrition/Vitamins from 2023 to 2033

Chemotherapy-Induced Nausea and Vomiting (CINV) Treatment Market

Chemotherapy-Induced Nausea and Vomiting (CINV) Treatment Market By Form (Injectables, Oral, Transdermal Patches), By Drug Class (5-HT3 Receptor Antagonists, Corticosteroids), By Emetogenik Risk, By Distribution Channel, By Region - Global Insights 2016 to 2031

Gastrointestinal Bleeding Treatment Market

Gastrointestinal Bleeding Treatment Market By Product (Endoscopic Hemostatic Devices, Thermal Devices, Mechanical Devices, Closure Devices), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End-users & By Regions - Global Market Insights 2020 - 2026

Nausea Relief Chews Market